Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$834M |
| 2 |
FedEx
FDX
|
+$666M |
| 3 |
Microsoft
MSFT
|
+$594M |
| 4 |
Advanced Micro Devices
AMD
|
+$585M |
| 5 |
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
|
+$403M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Walt Disney
DIS
|
+$2.17B |
| 2 |
Amazon
AMZN
|
+$1.98B |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.79B |
| 4 |
NVIDIA
NVDA
|
+$1.18B |
| 5 |
Wells Fargo
WFC
|
+$827M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 1.89% |
| 2 | Consumer Discretionary | 1.29% |
| 3 | Communication Services | 0.93% |
| 4 | Healthcare | 0.89% |
| 5 | Financials | 0.8% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
FNCH
1801
DELISTED
Finch Therapeutics Group, Inc. Common Stock
FNCH
| $23M | ﹤0.01% |
+59,029
| New | +$25.2M |
|
1802
CALL
Fulgent Genetics
FLGT
$549M
| $23M | ﹤0.01% |
255,800
-38,400
| -13% | -$3.49M |
|
1803
CALL
ProShares Ultra Bloomberg Crude Oil
UCO
$375M
| $23M | ﹤0.01% |
1,092,800
-352,800
| -24% | -$6.58M |
|
1804
PUT
GrowGeneration
GRWG
$101M
| $23M | ﹤0.01% |
932,300
-175,200
| -16% | -$6.19M |
|
1805
CALL
CRISPR Therapeutics
CRSP
$5.89B
| $23M | ﹤0.01% |
205,300
-189,800
| -48% | -$23.8M |
|
1806
PUT
Macerich
MAC
$6.88B
| $23M | ﹤0.01% |
1,374,900
-390,200
| -22% | -$6.62M |
|
1807
PUT
Rithm Capital
RITM
$5.68B
| $22.9M | ﹤0.01% |
2,086,000
+389,700
| +23% | +$4M |
|
1808
CALL
Southern Copper
SCCO
$186B
| $22.9M | ﹤0.01% |
446,051
-154,470
| -26% | -$8.84M |
|
1809
CALL
Invesco Mortgage Capital
IVR
$801M
| $22.9M | ﹤0.01% |
727,440
+28,380
| +4% | +$922K |
|
1810
Li Auto
LI
$12B
| $22.9M | ﹤0.01% |
870,891
+478,804
| +122% | +$14.4M |
|
1811
PUT
Canadian Natural Resources
CNQ
$102B
| $22.9M | ﹤0.01% |
1,274,412
+26,954
| +2% | +$444K |
|
1812
CALL
iShares Core S&P Small-Cap ETF
IJR
$111B
| $22.9M | ﹤0.01% |
209,400
+18,100
| +9% | +$1.99M |
|
|
1813
PUT
Southern Copper
SCCO
$186B
| $22.8M | ﹤0.01% |
444,195
-442,776
| -50% | -$25.3M |
|
1814
PUT
Intercontinental Exchange
ICE
$90.8B
| $22.8M | ﹤0.01% |
198,300
-68,000
| -26% | -$8.07M |
|
1815
PUT
Corsair Gaming
CRSR
$1.28B
| $22.7M | ﹤0.01% |
877,100
-122,000
| -12% | -$3.5M |
|
1816
CALL
NovoCure
NVCR
$2.05B
| $22.7M | ﹤0.01% |
195,200
-30,400
| -13% | -$4.6M |
|
1817
CALL
Consolidated Edison
ED
$39.6B
| $22.6M | ﹤0.01% |
311,600
-81,400
| -21% | -$6.08M |
|
1818
PUT
Tandem Diabetes Care
TNDM
$1.5B
| $22.6M | ﹤0.01% |
189,400
+76,900
| +68% | +$8.47M |
|
|
CTXS
1819
PUT
DELISTED
Citrix Systems Inc
CTXS
| $22.6M | ﹤0.01% |
210,500
+1,100
| +0.5% | +$119K |
|
1820
iShares Expanded Tech-Software Sector ETF
IGV
$14B
| $22.6M | ﹤0.01% |
283,035
+246,050
| +665% | +$20.1M |
|
1821
Baxter International
BAX
$13.6B
| $22.6M | ﹤0.01% |
280,664
-50,003
| -15% | -$3.95M |
|
1822
PUT
ProShares Trust UltraShort Lehman 20+ Year Treasury
TBT
$294M
| $22.6M | ﹤0.01% |
1,229,800
-285,000
| -19% | -$5M |
|
1823
Franklin Investment Grade Corporate ETF
FLCO
$560M
| $22.6M | ﹤0.01% |
869,505
+854,198
| +5,580% | +$22.5M |
|
|
DQ
1824
Daqo New Energy
DQ
$962M
| $22.6M | ﹤0.01% |
395,808
+91,629
| +30% | +$5.48M |
|
|
COOP
1825
PUT
DELISTED
Mr. Cooper
COOP
| $22.5M | ﹤0.01% |
547,400
+483,200
| +753% | +$18.2M |
|
Similar funds
Jeff Yass's Q3 2021 Portfolio in Review
As of Q3 2021, Jeff Yass held 14,193 positions worth $745B, up 4.8% from $712B the previous quarter. Its ten largest holdings account for 32% of the portfolio.
Jeff Yass deployed $45.4B of net new capital in Q3 2021, opening 1,741 new positions and adding to 5,205 existing holdings. Its largest new stake was InMode: 613,660 shares worth $48.9M.
By sector, the portfolio is most concentrated in Technology at 1.9% of assets, down from 1.9% a quarter earlier, followed by Consumer Discretionary and Communication Services.
On the sell side, the largest reduction was Walt Disney, an estimated $2.17B trimmed.
- Jeff Yass's largest Q3 2021 buy was InMode: 613,660 shares worth $48.9M.
- Jeff Yass added most to Zoom in Q3 2021, an estimated $834M increase.
- Jeff Yass's biggest Q3 2021 reduction was Walt Disney, cutting an estimated $2.17B.
- Jeff Yass fully exited PRA Health Sciences, Inc. in Q3 2021, selling an estimated $103M.
- Jeff Yass's ten largest holdings make up 32% of its $745B portfolio in Q3 2021.
- Jeff Yass opened 1,741 new positions and closed 1,559 in Q3 2021.
- Jeff Yass's portfolio value rose 4.8% quarter-over-quarter to $745B.
Based on Susquehanna International Group's 13F filing for Q3 2021, filed 15 Nov 2021.